Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Atractylenolide II is a sesquiterpene that has been found in D. metel and has diverse biological activities.1,2,3 It inhibits proliferation of, as well as halts the cell cycle at the G2/M phase and induces apoptosis in, DU145 and LNCaP prostate cancer cells when used at concentrations of 50 and 100 µM.1 Atractylenolide II also inhibits LPS-induced nitric oxide (NO) production in RAW 264.7 cells (IC50 = 17.73 µM).2 It increases Nrf2 protein levels when used at a concentration of 50 µM and reduces reactive oxygen species (ROS) production induced by irradiation in HaCaT cells.3 Atractylenolide II (60 mg/kg) prevents cutaneous and intestinal ulcers induced by irradiation in mice.
WARNING This product is not for human or veterinary use.
1. Atractylenolide II induces apoptosis of prostate cancer cells through regulation of AR and JAK2/STAT3 signaling pathways. Molecules 23(12), 3298 (2018).
2. Anti-
3. Atractylenolide II prevents radiation damage via MAPKp38/Nrf2 signaling pathway. Biochem. Pharmacol. 177, 114007 (2020).